Result of the AMSTAR-2 assessments. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Characteristics of included reviews. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Result of the PRISMA assessments. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Result of the ROBIS assessments. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Evolution of arterial redox potential during CPB. حسب Vincent Pey (21433304)

Supplementary Material for: Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis حسب Lin Y.-T. (17065287)

"…After transitioning to HD, body weight decreased significantly, with a reduction of -2.8 kg at one month, -5.3 kg at three months, and -7.5 kg one year post-transition. …"

A prepubertal CD decreases fat mass accumulation and prevents lean mass loss in adulthood despite a chronic HFD in Sprague-Dawley male rats. حسب Ana Aguilar-Lozano (20614619)

Pathological changes in lung tissue of mice exposed to continuous inhalation of CS. حسب Yue He (385239)

Pathways analysis of ERCC1 based on CWP metabolome and proteome. حسب Hao Deng (409186)

Procedure for attaching the eye drop bottle and instilling eye drops. حسب Yuka Kasai (21354922)

الموضوعات:

Demographics of the enrolled patients. حسب Yuka Kasai (21354922)

الموضوعات:

The video demonstrates how to use the eye drop aid. حسب Yuka Kasai (21354922)

الموضوعات:

Overhead view of the eye drop aid. حسب Yuka Kasai (21354922)

الموضوعات:

Comparison of eye drop instillation success rates across different age groups. حسب Yuka Kasai (21354922)

الموضوعات:

ONSD modifications induced by arterial paCO₂ changes. حسب Marco Carbonara (11483575)

الموضوعات:

Enrollment flow-chart. حسب Marco Carbonara (11483575)

الموضوعات:

Table 1 - حسب Marco Carbonara (11483575)

الموضوعات:

Optic Nerve Sheath Diameter (ONSD) in mm, measured by ultrasound. حسب Marco Carbonara (11483575)

الموضوعات:

ONSD at T14 and six months after ICU discharge. حسب Marco Carbonara (11483575)

الموضوعات:

Bland-Altman plot indicating the agreement between the optic nerve sheath diameter measured with CT scan and US. حسب Marco Carbonara (11483575)

الموضوعات: